Clinical Trials
33 trialsEfficacy and Safety of VasoClip® vs. WeckClip® for Robotic Urologic Surgery
Incheon St.Mary's Hospital
Evaluating Length of Treatment With PD-1/PD-L1 Inhibitor in Advanced Solid Tumors
University of Pittsburgh
S0931
SWOG Cancer Research Network
JAVELIN Renal 101
Pfizer
Robot-assisted Partial Nephrectomy With and Without Mixed Reality (REALITATEM Study)
Hospital Moinhos de Vento
CheckMate 914
Bristol-Myers Squibb
Axitinib (AG-013736) For the Treatment of Metastatic Renal Cell Cancer
Pfizer
Glutamic Acid in Reducing Nerve Damage Caused by Vincristine in Young Patients With Cancer
University of South Florida
Combination Chemotherapy Alone or With Radiation Therapy in Treating Children With Kidney Cancer
Children's Oncology Group
Axitinib (AG 013736) As Second Line Therapy For Metastatic Renal Cell Cancer
Pfizer
ARISER
Heidelberg Pharma AG
Mannitol Use During Partial Nephrectomy Prior to Renal Ischemia and Impact on Renal Function Outcomes
Memorial Sloan Kettering Cancer Center
Pre-surgical Detection of Clear Cell Renal Cell Carcinoma (ccRCC) Using Radiolabeled G250-Antibody
Heidelberg Pharma AG
S-TRAC
Pfizer
Interleukin-2 in Treating Patients With Stage III or Stage IV Kidney Cancer
Loyola University
Interferon Alfa-2b With or Without Bevacizumab in Treating Patients With Advanced Renal Cell Carcinoma (Kidney Cancer)
Alliance for Clinical Trials in Oncology
INTORACT
Pfizer
Surgery With or Without Chemotherapy in Treating Patients With Soft Tissue Sarcoma
European Organisation for Research and Treatment of Cancer - EORTC
Chemotherapy With or Without Surgery, Radiation Therapy, or Stem Cell Transplantation in Treating Young Patients With Kidney Tumors
Children's Oncology Group
Interferon Alfa With or Without Interleukin-2 and Fluorouracil in Treating Patients With Advanced Metastatic Kidney Cancer
National Cancer Institute (NCI)
Sorafenib in Treating Patients at Risk of Relapse After Undergoing Surgery to Remove Kidney Cancer
National Cancer Institute (NCI)
Interleukin-2 in Treating Patients With Metastatic Kidney Cancer
National Cancer Institute (NCI)
Kidney-Sparing Surgery Compared With Kidney Removal in Treating Patients With Kidney Cancer
European Organisation for Research and Treatment of Cancer - EORTC
AE-941 in Treating Patients With Metastatic Kidney Cancer
AEterna Zentaris
RECORD-1
Novartis
ARCC
Pfizer
Medroxyprogesterone or Interferon and/or Aldesleukin in Treating Patients With Metastatic Kidney Cancer
Centre Leon Berard
Interleukin-2 and Interferon in Treating Patients With Metastatic Kidney Cancer
Centre Leon Berard
Interleukin-2, Interferon Alfa, and Fluorouracil Compared With Observation in Treating Patients Who Have Undergone Surgery for Kidney Cancer
European Organisation for Research and Treatment of Cancer - EORTC
Survival Study Of Oncophage® vs. Observation In Patients With Kidney Cancer
Agenus Inc.
Interferon Alfa With or Without Isotretinoin in Treating Patients With Metastatic Kidney Cancer
European Organisation for Research and Treatment of Cancer - EORTC
Surgery With or Without Combination Chemotherapy in Treating Patients With Lung Metastases From Soft Tissue Sarcoma
European Organisation for Research and Treatment of Cancer - EORTC
Interferon Alfa-2b With or Without Thalidomide in Treating Patients With Metastatic or Unresectable Kidney Cancer
National Cancer Institute (NCI)